Chalice Brands Ltd (CHALF)
0.00
USD |
OTCM |
May 14, 16:00
Chalice Brands Total Assets (Quarterly): 44.37M for Sept. 30, 2021
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2021 | 44.37M |
| June 30, 2021 | 45.33M |
| March 31, 2021 | 37.87M |
| December 31, 2020 | 28.02M |
| September 30, 2020 | 28.87M |
| June 30, 2020 | 28.98M |
| March 31, 2020 | 30.52M |
| December 31, 2019 | 31.64M |
| September 30, 2019 | 68.55M |
| June 30, 2019 | 70.70M |
| March 31, 2019 | 73.45M |
| December 31, 2018 | 73.48M |
| September 30, 2018 | 84.22M |
| June 30, 2018 | 86.74M |
| Date | Value |
|---|---|
| March 31, 2018 | 92.56M |
| December 31, 2017 | 75.05M |
| September 30, 2017 | 71.37M |
| June 30, 2017 | 23.04M |
| March 31, 2017 | 22.55M |
| December 31, 2016 | 24.84M |
| September 30, 2016 | 23.70M |
| June 30, 2016 | 24.46M |
| March 31, 2016 | 24.61M |
| June 30, 2015 | 0.001M |
| March 31, 2015 | 0.001M |
| December 31, 2014 | 0.0933M |
| March 31, 2014 | 0.0982M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.02M
Minimum
Dec 2020
70.70M
Maximum
Jun 2019
41.48M
Average
34.76M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Liminal Biosciences Inc (DELISTED) | 23.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.58M |
| Shareholders Equity (Quarterly) | 16.43M |